8-K/A

CURRENT REPORT

Company: IOVANCE BIOTHERAPEUTICS, INC.
Filed: December 22, 2011
Period of Report: November 30, 2011
Accession Number: 0001144204-11-071233

View Document ↗ View on SEC.gov ↗